Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 June 2000:
Vol. 288. no. 5472, pp. 1822 - 1825
DOI: 10.1126/science.288.5472.1822
Prev | Table of Contents | Next

Reports

Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity

Robert X. Xu, 1 Anne M. Hassell, 1 Dana Vanderwall, 1 Millard H. Lambert, 1 William D. Holmes, 2 Michael A. Luther, 2 Warren J. Rocque, 2 Michael V. Milburn, 1 Yingdong Zhao, 3* Hengming Ke, 3dagger Robert T. Nolte 1dagger

Cyclic nucleotides are second messengers that are essential in vision, muscle contraction, neurotransmission, exocytosis, cell growth, and differentiation. These molecules are degraded by a family of enzymes known as phosphodiesterases, which serve a critical function by regulating the intracellular concentration of cyclic nucleotides. We have determined the three-dimensional structure of the catalytic domain of phosphodiesterase 4B2B to 1.77 angstrom resolution. The active site has been identified and contains a cluster of two metal atoms. The structure suggests the mechanism of action and basis for specificity and will provide a framework for structure-assisted drug design for members of the phosphodiesterase family.

1 Department of Structural Chemistry,
2 Department of Molecular Sciences, Glaxo Wellcome Research and Development, Research Triangle Park, NC 27709, USA.
3 Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
*   Present address: Molecular Statistics and Bioinformatics Section, National Cancer Institute, Bethesda, MD 20892, USA.

dagger    To whom correspondence should be addressed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Structural basis for the catalytic mechanism of human phosphodiesterase 9.
S. Liu, M. N. Mansour, K. S. Dillman, J. R. Perez, D. E. Danley, P. A. Aeed, S. P. Simons, P. K. LeMotte, and F. S. Menniti (2008)
PNAS 105, 13309-13314
   Abstract »    Full Text »    PDF »
Phosphodiesterase Isozymes Involved in Regulation of Formula Secretion in Isolated Mouse Stomach in Vitro.
K. Kita, K. Takahashi, Y. Ohashi, H. Takasuka, E. Aihara, and K. Takeuchi (2008)
J. Pharmacol. Exp. Ther. 326, 889-896
   Abstract »    Full Text »    PDF »
Conformational Variations of Both Phosphodiesterase-5 and Inhibitors Provide the Structural Basis for the Physiological Effects of Vardenafil and Sildenafil.
H. Wang, M. Ye, H. Robinson, S. H. Francis, and H. Ke (2008)
Mol. Pharmacol. 73, 104-110
   Abstract »    Full Text »    PDF »
cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling.
M. D. Houslay, G. S. Baillie, and D. H. Maurice (2007)
Circ. Res. 100, 950-966
   Abstract »    Full Text »    PDF »
From the Cover: Structural insight into substrate specificity of phosphodiesterase 10.
H. Wang, Y. Liu, J. Hou, M. Zheng, H. Robinson, and H. Ke (2007)
PNAS 104, 5782-5787
   Abstract »    Full Text »    PDF »
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A.
V. Vasta, M. Shimizu-Albergine, and J. A. Beavo (2006)
PNAS 103, 19925-19930
   Abstract »    Full Text »    PDF »
Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism.
P. M. Brown, T. T. Caradoc-Davies, J. M. J. Dickson, G. J. S. Cooper, K. M. Loomes, and E. N. Baker (2006)
PNAS 103, 15032-15037
   Abstract »    Full Text »    PDF »
New Insights from the Structure-Function Analysis of the Catalytic Region of Human Platelet Phosphodiesterase 3A: A ROLE FOR THE UNIQUE 44-AMINO ACID INSERT.
S.-H. Hung, W. Zhang, R. A. Pixley, B. A. Jameson, Y. C. Huang, R. F. Colman, and R. W. Colman (2006)
J. Biol. Chem. 281, 29236-29244
   Abstract »    Full Text »    PDF »
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use.
A. T. Bender and J. A. Beavo (2006)
Pharmacol. Rev. 58, 488-520
   Abstract »    Full Text »    PDF »
Multiple Conformations of Phosphodiesterase-5: IMPLICATIONS FOR ENZYME FUNCTION AND DRUG DEVELOPMENT.
H. Wang, Y. Liu, Q. Huai, J. Cai, R. Zoraghi, S. H. Francis, J. D. Corbin, H. Robinson, Z. Xin, G. Lin, et al. (2006)
J. Biol. Chem. 281, 21469-21479
   Abstract »    Full Text »    PDF »
The Inhibitory {gamma} Subunit of the Rod cGMP Phosphodiesterase Binds the Catalytic Subunits in an Extended Linear Structure.
L.-W. Guo, H. Muradov, A. R. Hajipour, M. K. Sievert, N. O. Artemyev, and A. E. Ruoho (2006)
J. Biol. Chem. 281, 15412-15422
   Abstract »    Full Text »    PDF »
Phosphodiesterase-5 Gln817 Is Critical for cGMP, Vardenafil, or Sildenafil Affinity: ITS ORIENTATION IMPACTS cGMP BUT NOT cAMP AFFINITY.
R. Zoraghi, J. D. Corbin, and S. H. Francis (2006)
J. Biol. Chem. 281, 5553-5558
   Abstract »    Full Text »    PDF »
Identification of a New Variant of PDE1A Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase Expressed in Mouse Sperm.
V. Vasta, W. K. Sonnenburg, C. Yan, S. H. Soderling, M. Shimizu-Albergine, and J. A. Beavo (2005)
Biol Reprod 73, 598-609
   Abstract »    Full Text »    PDF »
Structural Evidence for a Two-Metal-Ion Mechanism of Group I Intron Splicing.
M. R. Stahley and S. A. Strobel (2005)
Science 309, 1587-1590
   Abstract »    Full Text »    PDF »
Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7.
H. Wang, Y. Liu, Y. Chen, H. Robinson, and H. Ke (2005)
J. Biol. Chem. 280, 30949-30955
   Abstract »    Full Text »    PDF »
The Long and Short of Vascular Smooth Muscle Phosphodiesterase-4 As a Putative Therapeutic Target.
M. D. Houslay (2005)
Mol. Pharmacol. 68, 563-567
   Abstract »    Full Text »    PDF »
Preferential Inhibition of T Helper 1, but Not T Helper 2, Cytokines in Vitro by L-826,141 [4-{2-(3,4-Bisdifluromethoxyphenyl)-2-{4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl}-3-methylpyridine-1-oxide], a Potent and Selective Phosphodiesterase 4 Inhibitor.
D. Claveau, S. L. Chen, S. O'Keefe, D. M. Zaller, A. Styhler, S. Liu, Z. Huang, D. W. Nicholson, and J. A. Mancini (2004)
J. Pharmacol. Exp. Ther. 310, 752-760
   Abstract »    Full Text »    PDF »
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
Q. Huai, H. Wang, W. Zhang, R. W. Colman, H. Robinson, and H. Ke (2004)
PNAS 101, 9624-9629
   Abstract »    Full Text »    PDF »
Crystal Structures of Phosphodiesterases 4 and 5 in Complex with Inhibitor 3-Isobutyl-1-methylxanthine Suggest a Conformation Determinant of Inhibitor Selectivity.
Q. Huai, Y. Liu, S. H. Francis, J. D. Corbin, and H. Ke (2004)
J. Biol. Chem. 279, 13095-13101
   Abstract »    Full Text »    PDF »
G Protein Signaling: Insights from New Structures.
A. M. Preininger and H. E. Hamm (2004)
Sci. STKE 2004, re3
   Abstract »    Full Text »    PDF »
Relationships between Heme Incorporation, Tetramer Formation, and Catalysis of a Heme-regulated Phosphodiesterase from Escherichia coli: A STUDY OF DELETION AND SITE-DIRECTED MUTANTS.
T. Yoshimura, I. Sagami, Y. Sasakura, and T. Shimizu (2003)
J. Biol. Chem. 278, 53105-53111
   Abstract »    Full Text »    PDF »
Phosphodiesterase 7A-Deficient Mice Have Functional T Cells.
G. Yang, K. W. McIntyre, R. M. Townsend, H. H. Shen, W. J. Pitts, J. H. Dodd, S. G. Nadler, M. McKinnon, and A. J. Watson (2003)
J. Immunol. 171, 6414-6420
   Abstract »    Full Text »    PDF »
Regulation of T-Cell Activation by Phosphodiesterase 4B2 Requires Its Dynamic Redistribution during Immunological Synapse Formation.
J. Arp, M. G. Kirchhof, M. L. Baroja, S. H. Nazarian, T. A. Chau, C. A. Strathdee, E. H. Ball, and J. Madrenas (2003)
Mol. Cell. Biol. 23, 8042-8057
   Abstract »    Full Text »    PDF »
Attenuation of the Activity of the cAMP-specific Phosphodiesterase PDE4A5 by Interaction with the Immunophilin XAP2.
G. B. Bolger, A. H. Peden, M. R. Steele, C. MacKenzie, D. G. McEwan, D. A. Wallace, E. Huston, G. S. Baillie, and M. D. Houslay (2003)
J. Biol. Chem. 278, 33351-33363
   Abstract »    Full Text »    PDF »
Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram.
Y. Zhao, H.-T. Zhang, and J. M. O'Donnell (2003)
J. Pharmacol. Exp. Ther. 305, 565-572
   Abstract »    Full Text »    PDF »
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling.
M. Conti, W. Richter, C. Mehats, G. Livera, J.-Y. Park, and C. Jin (2003)
J. Biol. Chem. 278, 5493-5496
   Full Text »    PDF »
beta -Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta -adrenoceptor switching from Gs to Gi.
G. S. Baillie, A. Sood, I. McPhee, I. Gall, S. J. Perry, R. J. Lefkowitz, and M. D. Houslay (2003)
PNAS 100, 940-945
   Abstract »    Full Text »    PDF »
GAF Domains: Cyclic Nucleotides Come Full Circle.
J. H. Hurley (2003)
Sci. STKE 2003, pe1
   Abstract »    Full Text »    PDF »
Identification of a Novel Type of cGMP Phosphodiesterase That Is Defective in the Chemotactic stmF Mutants.
M. E. Meima, R. M. Biondi, and P. Schaap (2002)
Mol. Biol. Cell 13, 3870-3877
   Abstract »    Full Text »    PDF »
Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs).
W. Richter and M. Conti (2002)
J. Biol. Chem. 277, 40212-40221
   Abstract »    Full Text »    PDF »
Binding of cGMP to GAF Domains in Amphibian Rod Photoreceptor cGMP Phosphodiesterase (PDE). IDENTIFICATION OF GAF DOMAINS IN PDE alpha beta SUBUNITS AND DISTINCT DOMAINS IN THE PDE gamma SUBUNIT INVOLVED IN STIMULATION OF cGMP BINDING TO GAF DOMAINS.
M. Yamazaki, N. Li, V. A. Bondarenko, R. K. Yamazaki, W. Baehr, and A. Yamazaki (2002)
J. Biol. Chem. 277, 40675-40686
   Abstract »    Full Text »    PDF »
GAF Domains: Two-Billion-Year-Old Molecular Switches that Bind Cyclic Nucleotides.
S. E. Martinez, J. A. Beavo, and W. G.J. Hol (2002)
Mol. Interv. 2, 317-323
   Abstract »    Full Text »    PDF »
Identification of Interaction Sites of Cyclic Nucleotide Phosphodiesterase Type 3A with Milrinone and Cilostazol Using Molecular Modeling and Site-Directed Mutagenesis.
W. Zhang, H. Ke, and R. W. Colman (2002)
Mol. Pharmacol. 62, 514-520
   Abstract »    Full Text »    PDF »
Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.
A. Rascon, S. H. Soderling, J. B. Schaefer, and J. A. Beavo (2002)
PNAS 99, 4714-4719
   Abstract »    Full Text »    PDF »
Molecular Docking of Competitive Phosphodiesterase Inhibitors.
O. Dym, I. Xenarios, H. Ke, and J. Colicelli (2002)
Mol. Pharmacol. 61, 20-25
   Abstract »    Full Text »    PDF »
T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.
N. A. Glavas, C. Ostenson, J. B. Schaefer, V. Vasta, and J. A. Beavo (2001)
PNAS 98, 6319-6324
   Abstract »    Full Text »    PDF »
Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells.
M. Conti (2000)
Mol. Endocrinol. 14, 1317-1327
   Full Text »
Characterization of TbPDE2A, a Novel Cyclic Nucleotide-specific Phosphodiesterase from the Protozoan Parasite Trypanosoma brucei.
R. Zoraghi, S. Kunz, K. Gong, and T. Seebeck (2001)
J. Biol. Chem. 276, 11559-11566
   Abstract »    Full Text »    PDF »
Identification of the gamma Subunit-interacting Residues on Photoreceptor cGMP Phosphodiesterase, PDE6alpha '.
A. E. Granovsky and N. O. Artemyev (2000)
J. Biol. Chem. 275, 41258-41262
   Abstract »    Full Text »    PDF »
Partial Reconstitution of Photoreceptor cGMP Phosphodiesterase Characteristics in cGMP Phosphodiesterase-5.
A. E. Granovsky and N. O. Artemyev (2001)
J. Biol. Chem. 276, 21698-21703
   Abstract »    Full Text »    PDF »
The Catalytic and GAF Domains of the Rod cGMP Phosphodiesterase (PDE6) Heterodimer Are Regulated by Distinct Regions of Its Inhibitory gamma Subunit.
H. Mou and R. H. Cote (2001)
J. Biol. Chem. 276, 27527-27534
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)